NOV vs AROC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NOV · NOV Inc$16.02 ▼ 2.73%
AROC · Archrock$25.37 ▼ 5.30%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NOV +9.0%
- AROC +10.6%
Head to head
| Metric | NOV | AROC |
|---|---|---|
| Price | $16.02 | $25.37 |
| Change today | ▼ 2.73% | ▼ 5.30% |
| Market cap | $5.71B | $4.45B |
| Return, 3 months | -18.6% | -17.4% |
| Return, year to date | +4.3% | -0.6% |
| Return, 1 year | +9.6% | +10.9% |
| P/E (TTM) | 39.1 | 13.1 |
| P/B | 0.9 | 2.8 |
| P/E percentile vs own 5y | 75th | 0th |
| Dividend yield | 2.72% | 3.47% |
| Revenue growth (YoY, latest qtr) | +2.3% | -3.0% |
| Net profit growth (YoY) | +115.9% | +18.6% |
| Gross margin | 20.7% | 48.6% |
| Operating margin | 6.3% | 38.8% |
| Net margin | 1.6% | 22.7% |
| Return on equity | 2.3% | 22.4% |
| Analyst target vs. price | +42.8% | +64.6% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 27 | 34 |
| 30-day volatility | 37.1% | 56.1% |
| Max drawdown, 1 year | -25.9% | -39.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NOV is the largest of the group by market value.
- AROC has returned the most over the past year.
- AROC carries the lowest trailing P/E.
- AROC pays the highest dividend yield.
- NOV is growing revenue fastest.
- AROC keeps the most profit per dollar of sales.
- NOV has been the calmest stock over the last 30 days.